Small-scale clinical trials revealed that GLP-1 and GLP-1-based medicines may have positive effects on low-grade inflammation, blood pressure, cholesterol, and microcirculation ( Due to their various modes of action, which include vasodilation, natriuresis, glucose and weight control, and direct cardioprotective effects, GLP-1 receptor agonists have therapeutic potential for treatment of heart failure ( Obesity is a major cause of cardiovascular diseases
That 3-5mg shortfall means reduced appetite suppression, less metabolic benefit, and slower progress
It was also recently approved for obstructive sleep apnea in obese patients
Together, we can achieve your health goals while protecting our planet
Saxenda contains 3 mg of liraglutide per dose, while Victoza has a maximum of 1.8 mg
Through this journey, I also had the privilege of reconnecting and initiating collaboration with my PhD supervisor, Prof Maree Smith AC, and my former lab mate, Dr Andy Kuo, almost a decade later